Role of regulatory T-cells in H. pylori-induced gastritis and gastric cancer

Anticancer Research

Volumn 30, Issue 4, 2010, Pages 1093-1103

  Kandulski, Arne ^a   Malfertheiner, Peter ^a   Wex, Thomas ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

FOXP3; Gastric cancer; Regulatory T cells; Review; Treg cells

Indexed keywords

CD4 ANTIGEN; CELL SURFACE MARKER; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CANCER SURVIVAL; CD25+ T LYMPHOCYTE; CELL ACTIVITY; CELL CONTACT; CELL DIFFERENTIATION; CHRONIC GASTRITIS; CHRONIC INFLAMMATION; GASTRITIS; GENETIC SUSCEPTIBILITY; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; STOMACH CANCER;

ANIMALS; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 77953772080     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Kamangar F, Dores GM and Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150, 2006.
2. Roosendaal R, Kuipers EJ, Buitenwerf J, van Uffelen C, Meuwissen SG, van Kamp GJ and Vandenbroucke-Grauls CM: Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 92: 1480-1482, 1997.
3. Brenner H, Rothenbacher D and Arndt V: Epidemiology of stomach cancer. Methods Mol Biol 472: 467-477, 2009.
4. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S and Coebergh JW: Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44: 1345-1389, 2008.
5. El-Rifai W and Powell SM: Molecular biology of gastric cancer. Semin Radiat Oncol 12: 128-140, 2002.
6. Lynch HT, Silva E, Wirtzfeld D, Hebbard P, Lynch J and Huntsman DG: Hereditary diffuse gastric cancer: prophylactic surgical oncology implications. Surg Clin North Am 88: 759-778, 2008.
7. Peek RM Jr and Crabtree JE: Helicobacter infection and gastric neoplasia. J Pathol 208: 233-248, 2006.
8. Vauhkonen M, Vauhkonen H and Sipponen P: Pathology and molecular biology of gastric cancer. Best Pract Res Clin Gastroenterol 20: 651-674, 2006.
9. Correa P: A human model of gastric carcinogenesis. Cancer Res 48: 3554-3560, 1988.
10. Haraguchi N, Inoue H, Tanaka F, Mimori K, Utsunomiya T, Sasaki A and Mori M: Cancer stem cells in human gastrointestinal cancers. Hum Cell 19: 24-29, 2006.
11. Houghton J and Wang TC: Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 128: 1567-1578, 2005.
12. International Agency for Research on Cancer, World Health Organization: Infection with Helicobacter pylori, in Schistosomes, Liver Flukes and Helicobacter pylori, IARC Monograph, Eval. Carcinog Risks Hum Lyon, France 60: 177-220, 1994.
13. de Martel C and Franceschi S: Infections and cancer: established associations and new hypotheses. Crit Rev Oncol Hematol 70: 183-194, 2009.
14. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002.
15. Tsugane S and Sasazuki S: Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 10: 75-83, 2007.
16. Danesh J: Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 13: 851-856, 1999.
17. Suerbaum S and Michetti P: Helicobacter pylori infection. N Engl J Med 347: 1175-1186, 2002.
18. Amieva MR and El-Omar EM: Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 134: 306-323, 2008.
19. Malfertheiner P, Chan FK and McColl KE: Peptic ulcer disease. Lancet 374: 1449-1461, 2009.
20. Backert S and Selbach M: Role of type IV secretion in Helicobacter pylori pathogenesis. Cell Microbiol 10: 1573-1581, 2008.
21. Hatakeyama M: Linking epithelial polarity and carcinogenesis by multitasking Helicobacter pylori virulence factor CagA. Oncogene 27: 7047-7054, 2008.
22. Wen S and Moss SF: Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett 282: 1-8, 2009.
23. Torres J and Backert S: Pathogenesis of Helicobacter pylori infection. Helicobacter 13(Suppl 1): 13-17, 2008.
24. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Jr, and Rabkin CS: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-340, 2000. Erratum in: Nature 472: 99, 2001.
25. Hou L, El-Omar EM, Chen J, Grillo P, Rabkin CS, Baccarelli A, Yeager M, Chanock SJ, Zatonski W, Sobin LH, Lissowska J, Fraumeni JF, Jr, and Chow WH: Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis 28: 118-123, 2007. (Pubitemid 44942634)
26. Santini D, Angeletti S, Ruzzo A, Dicuonzo G, Galluzzo S, Vincenzi B, Calvieri A, Pizzagalli F, Graziano N, Ferraro E, Lorino G, Altomare A, Magnani M, Graziano F and Tonini G: Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes. Clin Exp Immunol 154: 360-364, 2008.
27. Zhang J, Dou C, Song Y, Ji C, Gu S, Xie Y and Mao Y: Polymorphisms of tumor necrosis factor-alpha are associated with increased susceptibility to gastric cancer: a meta-analysis. J Hum Genet 53: 479-489, 2008.
28. Crusius JB, Canzian F, Capellá G, Pera AS, Pera G, Sala N, Agudo A, Rico F, Del Giudice G, Palli D, Plebani M, Boeing H, Bueno-de-Mesquita HB, Carneiro F, Pala V, Save VE, Vineis P, Tumino R, Panico S, Berglund G, Manjer J, Stenling R, Hallmans G, Martínez C, Dorronsoro M, Barricarte A, Navarro C, Quirós JR, Allen N, Key TJ, Binghan S, Caldas C, Linseisen J, Kaaks R, Overvad K, Tjønneland A, Büchner FC, Peeters PH, Numans ME, Clavel-Chapelon F, Trichopoulou A, Lund E, Jenab M, Rinaldi S, Ferrari P, Riboli E and González CA: Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol 19: 1894-1902, 2008.
29. Wex T, Bornschein J and Malfertheiner P: Host polymorphisms of immune regulatory genes as risk factors for gastric cancer. MINERVA Gastroenterologica et Dietologica 55: 395-408, 2009.
30. Gianfagna F, De Feo E, van Duijn CM, Ricciardi G and Boccia S: A systematic review of meta-analyses on gene polymorphisms and gastric cancer risk. Curr Genomics 9: 361-374, 2008.
31. Kamangar F, Cheng C, Abnet CC and Rabkin CS: Interleukin-1B polymorphisms and gastric cancer risk - a meta-analysis. Cancer Epidemiol Biomarkers Prev 15: 1920-1928, 2006.
32. Lohoff M, Rollinghoff M and Sommer F: Helicobacter pylori gastritis: a Th1-mediated disease? J Biotechnol 83: 33-3, 2000.
33. D'Elios MM and Andersen LP: Helicobacter pylori inflammation, immunity, and vaccines. Helicobacter 12(Suppl 1): 15-9, 2007.
34. Goll R, Gruber F, Olsen T, Cui G, Raschpichler G, Buset M, Asfeldt AM, Husebekk A and Florholmen J: Helicobacter pylori stimulates a mixed adaptive immune response with a strong T-regulatory component in human gastric mucosa. Helicobacter 12: 185-192, 2007.
35. Vignali DA, Collison LW and Workman CJ: How regulatory T-cells work. Nat Rev Immunol 8: 523-532, 2008.
36. + regulatory T-cells. Curr Top Microbiol Immunol 293: 115-131, 2005. (Pubitemid 40791227)
37. + regulatory T-cells in immunological tolerance to self and non-self. Nat Immunol 6: 345-352, 2005.
38. Hori S, Nomura T and Sakaguchi S: Control of regulatory T-cell development by the transcription factor Foxp3. Science 299: 1057-1061, 2003.
39. Taams LS, Palmer DB, Akbar AN, Robinson DS, Brown Z and Hawrylowicz CM: Regulatory T-cells in human disease and their potential for therapeutic manipulation. Immunology 118: 1-9, 2003.
40. Zahorsky-Reeves JL and Wilkinson JE: The murine mutation scurfy (sf) results in an antigen dependent lymphoproliferative disease with altered T-cell sensitivity. Eur J Immunol 31: 196-204, 2001.
41. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF and Ochs HD: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27: 20-21, 2001.
42. van der Vliet HJ and Nieuwenhuis EE: PEX as a result of mutations in FOXP3. Clin Dev Immunol 2007: 89017, 2007.
43. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742, 1997.
44. + CD25 - precursors. Am J Transplant 4: 1614-1627, 2004.
45. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR and Belkaid Y: Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204: 1775-1785, 2007.
46. Izcue A and Powrie F: Special regulatory T-cell review: Regulatory T-cells and the intestinal tract - patrolling the frontier. Immunology 123: 6-10, 2008.
47. van Driel IR and Ang DK: Role of regulatory T-cells in gastrointestinal inflammatory disease. J Gastroenterol Hepatol 23: 171-177, 2008.
48. Ferrero RL: Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori. Mol Immunol 42: 879-885, 2005.
49. D'Elios MM and Andersen LP: Inflammation, immunity, and vaccines for Helicobacter pylori. Helicobacter 14(Suppl 1): 21-28, 2009.
50. Smith MF Jr, Mitchell A, Li G, Ding S, Fitzmaurice AM, Ryan K, Crowe S and Goldberg JB: Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 278: 32552-32560, 2003.
51. Moran AP, Hynes SO and Heneghan MA: Mimicry of blood group antigen A by Helicobacter mustelae and H. pylori. Gastroenterology 116: 504-505, 1999.
52. Cover TL and Blaser MJ: Helicobacter pylori in health and disease. Gastroenterology 136: 1863-1873, 2009.
53. Gebert B, Fischer W, Weiss E, Hoffmann R and Haas R: Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301: 1099-102, 2003.
54. Zabaleta J, McGee DJ, Zea AH, Hernández CP, Rodriguez PC, Sierra RA, Correa P and Ochoa AC: Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta). J Immunol 173: 586-593, 2004.
55. Schmees C, Prinz C, Treptau T, Rad R, Hengst L, Voland P, Bauer S, Brenner L, Schmid RM and Gerhard M: Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase. Gastroenterology 132: 1820-1833, 2007.
56. Wunder C, Churin Y, Winau F, Wamecke D, Vieth M, Lindner B, Zähringer U, Mollenkopf HJ, Heinz E and Meyer TF: Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med 12: 1030-1038, 2006.
57. Dixon MF, Genta RM, Yardley JH and Correa P: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20: 1161-1181, 1996.
58. + T-cell lineage differentiation. Immunity 30: 646-655, 2009.
59. Wilson KT and Crabtree JE: Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 133: 288-308, 2007.
60. D'Elios MM, Manghetti M, Almerigogna F, Amedei A, Costa F, Burroni D, Baldari CT, Romagnani S, Telford JL and Del Prete G: Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T-cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol 27: 1751-1755, 1997.
61. Michetti P and Svennerholm AM: Helicobacter pylori-inflammation, immunity and vaccines. Helicobacter 8(Suppl 1): 31-5, 2003.
62. Eaton KA, Mefford M and Thevenot T: The role of T-cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol 166: 7456-7461, 2001.
63. Annunziato F, Cosmi L, Liotta F, Maggi E and Romagnani S: Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol J: 325-331, 2009.
64. Monteleone I, Pallone F and Monteleone G: Interleukin-23 and Th17 cells in the control of gut inflammation. Mediators Inflamm 2009: 297645, 2009.
65. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H and Taniguchi M: CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278: 1626-1629, 1997.
66. Treiner E, Duban L, Moura IC, Hansen T, Gilfillan S and Lantz O: Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T-cell subset. Microbes Infect 7: 552-559, 2005.
67. Wingender G and Kronenberg M: Role of NKT cells in the digestive system. IV. The role of canonical natural killer T-cells in mucosal immunity and inflammation. Am J Physiol Gastrointest Liver Physiol 294: G1-8, 2008.
68. O'Keeffe J and Moran AP: Conventional, regulatory, and unconventional T-cells in the immunologic response to Helicobacter pylori. Helicobacter 13: 1-19, 2008.
69. Ambrosino E, Berzofsky JA and Terabe M: Regulation of tumor immunity: the role of NKT cells. Expert Opin Biol Ther 8: 725-734, 2008.
70. Orentas RJ, Kohler ME and Johnson BD: Suppression of anti-cancer immunity by regulatory T-cells: back to the future. Semin Cancer Biol 16: 137-149, 2006.
71. Sakaguchi S, Sakaguchi N, Asano M, Itoh M and Toda M: Immunologic self-tolerance maintained by activated T-cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164, 1995.
72. Asano M, Toda M, Sakaguchi N and Sakaguchi S: Autoimmune disease as a consequence of developmental abnormality of a T-cell subpopulation. J Exp Med 184: 387-396, 1996. (Pubitemid 26324092)
73. + regulatory T-cells inhibit the antigen-dependent expansion of self-reactive T-cells in vivo. J Immunol 176: 1609-1617, 2006.
74. + T-cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector T-cells. J Immunol 175: 7135-7142, 2005.
75. Huter EN, Stummvoll GH, DiPaolo RJ, Glass DD and Shevach EM: Cutting edge: antigen-specific TGF beta-induced regulatory T-cells suppress Th17-mediated autoimmune disease. J Immunol 181: 8209-8213, 2008.
76. Huter EN, Stummvoll GH, DiPaolo RJ, Glass DD and Shevach EM: Pre-differentiated Th1 and Th17 effector T-cells in autoimmune gastritis: Ag-specific regulatory T-cells are more potent suppressors than polyclonal regulatory T-cells. Int Immunopharmacol 9: 540-5, 2009.
77. + suppressor T-cells regulate pathogen induced inflammation and disease. FEMS Immunol Med Microbiol 44: 121-127, 2005.
78. high regulatory T-cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 71: 1755-1762, 2003.
79. Strömberg E, Edebo A, Lundin BS, Bergin P, Brisslert M, Svennerholm AM and Lindholm C: Down-regulation of epithelial IL-8 responses in Helicobacter pylori-infected duodenal ulcer patients depends on host factors, rather than bacterial factors. Clin Exp Immunol 140: 117-125, 2005.
80. +) in the antrum and cardia are associated with higher H. pylori colonization and increased gene expression of TGF-beta1. Helicobacter 13: 295-303, 2008.
81. Jang TJ: The number of Foxp3-positive regulatory T-cells is increased in Helicobacter pylori gastritis and gastric cancer. Pathol Res Pract 206: 34-38, 2010.
82. Kindlund B, Sjöling A, Hansson M, Edebo A, Hansson LE, Sjövall H, Svennerholm AM and Lundin BS: FOXP3-expressing CD4(+) T-cell numbers increase in areas of duodenal gastric metaplasia and are associated with CD4(+) T-cell aggregates in the duodenum of Helicobacter pylori-infected duodenal ulcer patients. Helicobacter 14: 192-201, 2009.
83. Robinson K, Kenefeck R, Pidgeon EL, Shakib S, Patel S, Poison RJ, Zaitoun AM and Atherton JC: Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T-cell responses. Gut 57: 1375-1385, 2008.
84. Kandulski A, Wex T, Kuester D, Mönkemüller K, Peitz U, Roessner A and Malfertheiner P: Chronic mucosal inflammation of the gastric cardia in gastroesophageal reflux disease is not regulated by FOXP3-expressing T-cells. Dig Dis Sci 54: 1940-1946, 2009.
85. Harris PR, Wright SW, Serrano C, Riera F, Duarte I, Torres J, Peña A, Rollán A, Viviani P, Guiraldes E, Schmitz JM, Lorenz RG, Novak L, Smythies LE and Smith PD: Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 134: 491-499, 2008.
86. Oderda G, Vivenza D, Rapa A, Boldorini R, Bonsignori I and Bona G: Increased interleukin-10 in Helicobacter pylori infection could be involved in the mechanism protecting from allergy. J Pediatr Gastroenterol Nutr 45: 301-305, 2007.
87. Daugule I and Rowland M: Helicobacter pylori infection in children. Helicobacter 13(Suppl 1): 41-6, 2008.
88. + regulatory T-cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice. Clin Exp Immunol 132: 393-400, 2003.
89. + T-cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 131: 525-537, 2006.
90. -/- mice, but only wild-type regulatory T-cells suppress Helicobacter pylori gastritis. Infect Immun 75: 2699-2707, 2007.
91. Matsumoto Y, Blanchard TG, Drakes ML, Basu M, Redline RW, Levine AD and Czinn SJ: Eradication of Helicobacter pylori and resolution of gastritis in the gastric mucosa of IL-10-deficient mice. Helicobacter 10: 407-415, 2005.
92. + regulatory T-cells modulate the T-cell and antibody responses in helicobacter-infected BALB/c mice. Infect Immun 74: 3519-3529, 2006.
93. + T-cells induce Helicobacter pylori-specific CD25- T-cell anergy but are not required to maintain persistent hyporesponsiveness. Eur J Immunol 38: 3426-3435, 2008.
94. Alam MS, Kurtz CC, Rowlett RM, Reuter BK, Wiznerowicz E, Das S, Linden J, Crowe SE and Ernst PB: CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice. J Infect Dis 199: 494-504, 2009.
95. Del Giudice G, Malfertheiner P and Rappuoli R: Development of vaccines against Helicobacter pylori. Expert Rev Vaccines 8: 1037-1049, 2009.
96. + T-cell-mediated IFN-gamma response to Helicobacter infection is essential for clearance and determines gastric cancer risk. J Immunol 182: 7085-7101, 2009.
97. Aebischer T, Bumann D, Epple HJ, Metzger W, Schneider T, Cherepnev G, Walduck AK, Kunkel D, Moos V, Loddenkemper C, Jiadze I, Panasyuk M, Stolte M, Graham DY, Zeitz M and Meyer TF: Correlation of T-cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines. Gut 57: 1065-1072, 2008.
98. Velin D, Favre L, Bernasconi E, Bachmann D, Pythoud C, Saiji E, Bouzourene H and Michetti P: Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology 136: 2237-2246, 2009.
99. Enarsson K, Lundgren A, Kindlund B, Hermansson M, Roncador G, Banham AH, Lundin BS and Quiding-Järbrink M: Function and recruitment of mucosal regulatory T-cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma. Clin Immunol 121: 358-368, 2006.
100. + H. pylori infection is associated with polarization of T helper cell immune responses in gastric carcinogenesis: World J Gastroenterol 13: 2923-2931, 2007.
101. Shen LS, Wang J, Shen DF, Yuan XL, Dong P, Li MX, Xue J, Zhang FM, Ge HL and Xu D: CD4(+)CD25(+)CD127(low/-) regulatory T-cells express Foxp3 and suppress effector T-cell proliferation and contribute to gastric cancer progression. Clin Immunol 131: 109-118, 2009.
102. Perrone G, Ruffini PA, Catalano V, Spino C, Santini D, Muretto P, Spoto C, Zingaretti C, Sisti V, Alessandroni P, Giordani P, Cicetti A, D'Emidio S, Morini S, Ruzzo A, Magnani M, Tonini G, Rabitti C and Graziano F: Intratumoural FOXP3-positive regulatory T-cells are associated with adverse prognosis in radically resected gastric cancer. Eur J Cancer 44: 1875-1882, 2008.
103. + regulatory T-cells is associated with clinical behaviour in gastric cancer. Br J Cancer 98: 148-153, 2008.